March 14, 2018 / 11:43 AM / in 3 months

BRIEF-Intellia Therapeutics Reports Qtrly Net Loss Per Share $0.61

* INTELLIA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

* COLLABORATION REVENUE WAS $6.7 MILLION FOR Q4 OF 2017, COMPARED TO $5.6 MILLION FOR Q4 OF PRIOR YEAR

* QTRLY NET LOSS PER SHARE $0.61

* Q4 EARNINGS PER SHARE VIEW $-0.42, REVENUE VIEW $8.6 MILLION — THOMSON REUTERS I/B/E/S

* INTELLIA - EXPECTS CASH, CASH EQUIVALENTS AS OF DEC 31, 2017, OTHER FUNDING WILL FUND OPERATING EXPENSES AND CAPEX THROUGH MID-2020

* INTELLIA THERAPEUTICS - HAD ‍$341 MILLION IN CASH AND CASH EQUIVALENTS AS OF DECEMBER 31, 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below